Healthcarenews

Name	:	healthcarenews
Website	:	Visit Website
Blog	:	Visit Blog
Social Links	:

About Healthcarenews

Over 5 years of Solid Experience performing market research. Uncommon ability to analyze and interpret information. Quantitative market research skills and experience using statistical analysis tools. Remarkable knowledge of or willingness to learn usability and human factors research methodologies. Sound knowledge of Healthcare Sector. Uncommon ability to work under a fast paced and dynamic environment. Extensive experience with various market research techniques to assess customer satisfaction, customer segmentation, visual appeal, brand perception, and usage pattern.

Spinal Implants Market worth $14.3 billion by 2028

Healthcarenews26 Jun, 2024Business

The global Spinal Implants Market in terms of revenue was estimated to be worth $11.2 billion in 2023 and is poised to reach $14.3 billion by 2028, growing at a CAGR of 5.0% from 2023 to 2028 according to a new report by MarketsandMarkets?. The expansion of the spinal implants market is propelled by several synergistic factors, including increasing demand for minimally invasive surgical procedures, escalating spinal disorder prevalence, rising geriatric patient population, growing public-private investments to support for the clinical research and the presence of key market players in developing regions.

Blood Screening Market worth $3.8 billion by 2026

Healthcarenews26 Jun, 2024Business

According to the new market research report "Blood Screening Market by Technology (Nucleic Acid Amplification, (Real-Time PCR), ELISA (Chemiluminescence immunoassay), Rapid Test, Western Blot), Product (Instrument, Reagent & Kits, Software) & End User (Blood Bank, Hospital) - Global Forecast to 2026", published by MarketsandMarkets?, the global market is projected to reach USD 3.8 billion by 2026 from USD 2.5 billion in 2021, at a CAGR of 8.4%.

ECG Market worth $11.3 billion By 2028

Healthcarenews26 Jun, 2024Business

Diagnostic Electrocardiograph (ECG) Market in terms of revenue was estimated to be worth $8.1 billion in 2023 and is poised to reach $11.3 billion by 2028, growing at a CAGR of 6.9% from 2023 to 2028 according to a new report by MarketsandMarkets?. Increasing incidence of cardiovascular and lifestyle diseases, growing demand for the early and continuous diagnosis, rising aging population with heart conditions and technological advancements in wearable ECG devices are expected to support the diagnostic ECG market growth.

Cleanroom Technologies Market Size, Share and Growth Trends

Healthcarenews24 Jun, 2024Business

According to the report titled "Cleanroom Technologies Market by Product (Equipment - Fan Filter, HVAC, Vacuum Systems; Consumable - Safety, Disinfectants), Type (Standard Modular (Hardwall, Softwall), Mobile), End User (Pharma, Biotech, MedTech, Hospitals) - Global Forecast to 2028," the market is projected to expand from USD 8.2 billion in 2023 to USD 11.4 billion by 2028, at a compound annual growth rate (CAGR) of 6.8%.

APAC Spatial Genomics and Transcriptomics Market worth $152 million

Healthcarenews24 Jun, 2024Business

The Asia Pacific spatial genomics and transcriptomics market is experiencing rapid growth, projected to reach USD 152 million by 2027 from USD 64 million in 2022. This represents a remarkable compound annual growth rate (CAGR) of 18.9% during the forecast period. Several key factors are driving this expansion, including the increasing adoption of advanced genomic techniques for drug discovery and development, substantial R&D investments, and significant public-private funding.

Mental Health Screening Market worth $1.8 billion by 2029

Healthcarenews20 Jun, 2024Business

The global Mental Health Screening market is on a robust growth trajectory, projected to reach USD 1.8 billion by 2029 from USD 0.9 billion in 2023, reflecting a steady CAGR of 12.2%. This growth is fueled by several key factors, including the expanding geriatric population, heightened awareness of mental health issues, and advancements in technology facilitating remote monitoring and screening methodologies.

Real World Evidence Solutions Market worth $4.5 billion by 2029

Healthcarenews20 Jun, 2024Business

The global Real World Evidence Solutions market is poised for substantial growth, projected to reach USD 4.5 billion by 2029 from USD 2.0 billion in 2024, reflecting a robust CAGR of 16.9%. This surge is driven by pivotal factors such as the increasing shift towards value-based healthcare and the rising aging population. Furthermore, the prevalence of chronic diseases and advancements in pharmaceutical and medical device innovations are accelerating the adoption of Real World Evidence (RWE) solutions, fueling market expansion.

Minimally Invasive Surgical Instruments Market worth $49.9 billion by 2029

Healthcarenews20 Jun, 2024Business

The minimally invasive surgical devices market is projected to reach USD 49.9 billion by 2029 from USD 31.7 billion in 2024, at a CAGR of 9.5% during the forecast period. The expansion of the minimally invasive surgical instruments market is predominantly driven by significant factors such as the superiority of MIS compared to conventional open surgical techniques, the increasing incorporation of advanced robotics in ASCs, and the worldwide surge in surgical procedure volumes.

Genotyping Assay Market Size, Share & Growth Trends

Healthcarenews19 Jun, 2024Business

The global genotyping assay market is projected to grow from USD 19.4 billion in 2024 to USD 37.1 billion by 2029, achieving a robust CAGR of 13.8% during the forecast period. This rapid expansion is driven by technological advancements, reduced DNA sequencing costs, and an increased prevalence of hereditary illnesses.

Spatial Genomics and Transcriptomics Market Size, Share and Trends

Healthcarenews19 Jun, 2024Business

The report Spatial Genomics and Transcriptomics Market Projected to surge from USD 355 million in 2022 to USD 800 million by 2027, growing at a CAGR of 17.6%. This growth is propelled by several key factors, including the increasing adoption of spatial genomics and transcriptomics techniques in drug discovery and development, coupled with rising R&D investments and public-private funding.